UA89111U - Method for treating antiphospholipid syndrome - Google Patents

Method for treating antiphospholipid syndrome

Info

Publication number
UA89111U
UA89111U UAU201313064U UAU201313064U UA89111U UA 89111 U UA89111 U UA 89111U UA U201313064 U UAU201313064 U UA U201313064U UA U201313064 U UAU201313064 U UA U201313064U UA 89111 U UA89111 U UA 89111U
Authority
UA
Ukraine
Prior art keywords
antiphospholipid syndrome
treating antiphospholipid
treating
homocysteine content
therapy
Prior art date
Application number
UAU201313064U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Сергій Вікторович Шевчук
Галина Вікторівна Безсмертна
Інна Петрівна Кувікова
Original Assignee
Науково-Дослідний Інститут Реабілітації Інвалідів (Навчально-Науково-Лікувальний Комплекс) Вінницького Національного Медичного Університету Ім. М.І. Пирогова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Науково-Дослідний Інститут Реабілітації Інвалідів (Навчально-Науково-Лікувальний Комплекс) Вінницького Національного Медичного Університету Ім. М.І. Пирогова filed Critical Науково-Дослідний Інститут Реабілітації Інвалідів (Навчально-Науково-Лікувальний Комплекс) Вінницького Національного Медичного Університету Ім. М.І. Пирогова
Priority to UAU201313064U priority Critical patent/UA89111U/en
Publication of UA89111U publication Critical patent/UA89111U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for treating antiphospholipid syndrome provides for the background therapy (diet, glucocorticosteroids, immunosuppressive agents, anticoagulants). Homocysteine content is measured in blood serum. When homocysteine content exceeds 15 µmol/L, the treatment is supplemented with pulse therapy with Metipred, 1 g for three days.
UAU201313064U 2013-11-11 2013-11-11 Method for treating antiphospholipid syndrome UA89111U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201313064U UA89111U (en) 2013-11-11 2013-11-11 Method for treating antiphospholipid syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201313064U UA89111U (en) 2013-11-11 2013-11-11 Method for treating antiphospholipid syndrome

Publications (1)

Publication Number Publication Date
UA89111U true UA89111U (en) 2014-04-10

Family

ID=56267271

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201313064U UA89111U (en) 2013-11-11 2013-11-11 Method for treating antiphospholipid syndrome

Country Status (1)

Country Link
UA (1) UA89111U (en)

Similar Documents

Publication Publication Date Title
CA2909335C (en) Fenfluramine for use in the treatment of dravet syndrome
EP3054954A4 (en) Hdac inhibitors, alone or in combination with btk inhibitors, for treating non-hodgkin's lymphoma
EP3054953A4 (en) Hdac inhibitors, alone or in combination with pi3k inhibitors, for treating non-hodgkin's lymphoma
MX2019015604A (en) Methods of treating a tauopathy.
MX2015017807A (en) Integrated closed iv line draw system.
EP3023786A4 (en) Blood analysis method, control device, and blood cell analyzer
EP4321866A3 (en) Gdf-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers
EP3061470A4 (en) Metal medical device having lubricity and low protein adsorption properties and/or low cell adsorption properties, and method for producing same
MY173304A (en) Induction of immune tolerance using methotrexate
EP3169228A4 (en) Device and method suitable for monitoring arterial blood in body part
WO2014106825A3 (en) Methods and devices for identifying improper medical reporting
MX2015010023A (en) Anti-cd83 antibodies and use thereof.
MX2016005064A (en) Immersion device.
UA89111U (en) Method for treating antiphospholipid syndrome
UA89126U (en) Method for treating antiphospholipid syndrome
GEP20197004B (en) Iron (iii) hydroxide complexes with activated glucose syrups and process for preparing same
GB2543709A (en) Pharmaceutical agent
UA91048U (en) Method for treating antiphospholipid syndrome
UA89110U (en) Method for treating antiphospholipid syndrome
UA91047U (en) Method for treating antiphospholipid syndrome
UA89107U (en) Method for treating antiphospholipid syndrome
UA89104U (en) Method for treating antiphospholipid syndrome
UA89109U (en) Method for treating antiphospholipid syndrome
WO2017075397A8 (en) Treatment regimen compliance modification system
UA89128U (en) Method for treating antiphospholipid syndrome